Hexavalent chromium is a known carcinogen linked to increased cancer risk. California has adopted a 10 ppb maximum contaminant level (MCL) for Cr(VI), creating a compliance imperative for utilities across the state. Conventional treatment approaches typically rely on ion exchange or reverse osmosis — technologies that generate concentrated brine waste streams, drive up energy costs, and remain prohibitively expensive for smaller systems serving disadvantaged communities.

The NIEHS-funded program rigorously demonstrated that Microvi's MNE™ biocatalyst platform can biologically reduce Cr(VI) to its non-toxic trivalent form (Cr(III)) at commercial scale, with consistent compliance performance and a dramatically lower operating cost profile than conventional alternatives. The system produces no brine, requires no specialty chemicals, and operates at ambient pressure and temperature.

"Cr(VI) is one of the most consequential drinking-water compliance challenges of the next decade," said Dr. Fatemeh Shirazi, CEO of Microvi. "The communities that need the safest water often have the least ability to pay for it. Our biological approach changes that math — and the NIEHS program is the rigorous, independent validation the industry needed."

With the program complete, Microvi is now engaging directly with California water utilities and disadvantaged community systems to deploy commercial-scale Cr(VI) treatment trains. The technology is also positioned to address legacy chromium contamination at industrial remediation sites.

Nebraska sits in the heart of agricultural America — and at the center of one of the nation's most persistent groundwater contamination challenges. Nitrate concentrations in private and municipal wells across the state have been trending upward for decades, driven by fertilizer runoff, livestock operations, and historical agricultural practices. For small and mid-sized utilities, the cost of conventional nitrate treatment — typically ion exchange or reverse osmosis — has been the primary barrier to compliance.

Fairbury, Nebraska is the first Nebraska city to pilot Microvi's Denitrovi™ biological nitrate treatment system, deploying the technology simultaneously at two municipal well sites. The pilot has achieved 78% nitrate removal at East Well #3 and 90% removal at Crystal Springs Well — both meeting the city's compliance targets without producing brine waste, without specialty chemical consumption, and at a fraction of the operating cost of conventional alternatives.

"What we needed was a treatment technology that could meet our compliance obligations without bankrupting our ratepayers," said the Fairbury Utilities team. "Microvi's Denitrovi system has delivered the removal performance we required, and the operations team has been able to run it without specialized expertise."

The Fairbury pilot is a template for hundreds of similar small and mid-sized communities across the Midwest grappling with the same regulatory and economic pressures. Microvi is now in active discussions with utilities across Nebraska, Iowa, Kansas, and the broader agricultural belt.

Phosphorus is both a critical agricultural nutrient and a leading cause of waterway eutrophication. UK and EU regulations require ever-tighter phosphorus discharge limits from wastewater treatment facilities — typically enforced through aggressive chemical dosing with iron or aluminum coagulants. Those chemicals achieve compliance, but at significant cost: they consume reagents, generate inert chemical sludge for landfilling, and lock recovered phosphorus into forms that have no agricultural value.

Microvi's Bio-Mineral Phosphorus Removal (BMPR) technology, developed in partnership with Cranfield University, takes a fundamentally different approach. The MNE™-encapsulated biological system directly mineralizes phosphorus into a recoverable form — achieving 97% phosphorus removal while producing a high-value mineral product that can be returned to agricultural soils.

Following its win at Ofwat's Water Discovery Challenge and recognition from The Earthshot Prize, BMPR has progressed to its largest demonstration yet: a deployment at Severn Trent's Minworth facility — one of the largest wastewater treatment plants in the United Kingdom.

"What BMPR represents is the closing of a planetary nutrient loop," said Dr. Shirazi. "For decades, our industry's approach to phosphorus has been to chemically immobilize it and then bury it. With BMPR, the same phosphorus that would have been lost to landfill becomes the input to next season's harvest. That is a fundamentally different relationship with the resource."

The UK water sector is moving toward Nitrogen Treatment Technically Achievable Limits (N-TAL) — a regulatory framework that pushes total nitrogen discharge below what conventional biological treatment can reliably achieve. The challenge falls hardest on smaller wastewater facilities, where conventional retrofit costs are disproportionately high relative to the population served.

South West Water has selected Microvi's containerized MNE™ biological treatment system as one of just three trial technologies for its N-TAL program. The decision reflects growing industry recognition that the next generation of nitrogen treatment will require a fundamentally smaller, more energy-efficient, and more deployable approach than the activated-sludge platforms designed for the previous century of wastewater treatment.

Microvi's containerized MNE™ system is delivered as a complete, drop-in unit that integrates directly into existing site infrastructure. The system uses encapsulated nitrifying and denitrifying biological consortia to achieve nitrogen removal at footprints 5–10× smaller than equivalent conventional technologies, with a fraction of the energy demand.

The South West Water trial follows the same pattern that has driven Microvi's deployment record across the UK and EU water sector: a regulated utility seeking a defensible compliance pathway for ultra-low nutrient limits, evaluating biological approaches that can be commissioned in months rather than years.

The American Water Works Association (AWWA) has published Manual M80: Biological Drinking Water Treatment — the first comprehensive industry reference dedicated to the use of biological processes in drinking water production. The manual codifies design, operations, and compliance practices for an approach that has historically been treated as experimental within the US drinking water sector.

Microvi's commercial-scale nitrate treatment system at the Sunny Slope Water Company in Pasadena, California is featured as a primary case study in the manual. The Sunny Slope deployment has operated continuously for years, providing safe, compliant drinking water to tens of thousands of households at a cost-effective per-volume rate that conventional ion-exchange systems cannot match.

Inclusion in M80 represents a significant signal to the US drinking water industry. Manual designations from AWWA effectively establish the practices that engineering firms, regulators, and utility procurement teams use to evaluate technology selection. Microvi's MNE™ platform — and the Sunny Slope reference — now sits within the formal industry knowledge base for biological drinking water treatment in North America.

"For the engineering and regulatory community, the M80 designation is a different kind of validation than commercial performance," said Dr. Shirazi. "It tells the design firm, the procurement officer, and the state regulator that biological drinking water treatment is no longer emerging — it is the established practice for the problems it solves."

Los Angeles County Sanitation Districts (LACSD) is the largest public utility in California, serving a population of more than 5.6 million people across 78 cities. The agency operates one of the most complex wastewater treatment systems in the United States and has long been at the forefront of regulatory science for water resource recovery.

LACSD has officially launched an independent, fully funded demonstration of Microvi's Denitrovi™ biosolution at its Albert Kendall Warren Water Resource Facility. The demonstration will support long-term scientific study of biological partial denitrification as part of LACSD's commitment to reducing the discharge of inorganic nitrogen into Southern California's aquatic environment.

Denitrovi™ is built on Microvi's MNE™ encapsulated biocatalyst platform. By immobilizing denitrifying organisms in a structured matrix, the system achieves higher process intensification, more predictable performance, and substantially smaller physical footprint than conventional suspended-growth denitrification systems.

An independent, utility-funded demonstration at LACSD is one of the most consequential validation events available in the Western US water sector. Outcomes from the Albert Kendall Warren program will be made publicly available and are expected to inform regulatory and procurement decisions across the region for years.

Conventional nitrogen removal in wastewater treatment is energy-intensive, chemical-dependent, and produces large volumes of biosolids that themselves require energy-intensive downstream handling. For the wastewater sector to credibly contribute to climate goals, those embedded costs — and the carbon emissions that go with them — have to come out of the process.

A California Energy Commission-funded program at Linda County Water District has completed a 2.5-year full-scale demonstration of Microvi's MNE™ platform integrated with advanced primary treatment. The results: total nitrogen consistently below 8 mg-N/L, achieved with no chemical addition, an ultra-compact treatment footprint, and near-zero excess biological solids.

The Linda County program is the first full-scale operational integration of advanced primary treatment and biological nitrogen removal in a single holistic system — combining carbon diversion (where organic carbon is preserved upstream for energy recovery rather than oxidized to CO₂) with downstream biological nitrogen removal that requires no external carbon source.

"This is what the next decade of wastewater treatment looks like," said Dr. Shirazi. "Compact. Energy-positive. Low-carbon. Without sacrificing compliance, and without depending on chemical inputs that themselves carry significant embedded emissions. The Linda County results show that this is no longer aspirational — it is operational."

2024 was a defining year for Microvi. We strengthened our commitment to advancing the widespread adoption of our platform — ushering in a new era of biosolutions to address critical challenges in climate change, water, energy, waste, health, and environmental sustainability.

Across the year, our team delivered new commercial deployments, advanced multiple federal and state-funded research programs to maturity, won the Ofwat Water Discovery Challenge in partnership with Cranfield University, and welcomed several new utility and industrial customers. We expanded our facilities in Hayward, California and grew the team across R&D, engineering, business development, and operations.

Behind every milestone is a community whose drinking water, wastewater, or industrial process became more sustainable, more affordable, or more resilient than it was the year before. Those are the metrics we measure ourselves against — and they are the metrics that make this work worth doing.

We are grateful to the partners, customers, investors, advisors, and team members who made 2024 what it was — and we are looking forward to what 2025 brings.

The San Francisco Bay Area is approaching one of the most consequential regulatory transitions in its recent history. New nutrient discharge regulations targeting nitrogen loading into the Bay will compel many of the region's largest wastewater treatment facilities to dramatically reduce their effluent nitrogen — at a scale and capital cost that the conventional toolkit is poorly suited to address.

The California Water Environment Association (CWEA) hosted its Navigating Nutrient Removal Workshop on June 20, 2024 in Walnut Creek to bring utilities, regulators, and technology providers together around exactly that challenge. Microvi presented on innovative nutrient removal technologies, with particular focus on the operational track record at the Oro Loma Sanitary District sidestream deployment — now in its third year of continuous operation in the Bay Area.

Workshops like CWEA's are where the regulatory framework, the engineering practice, and the available technology pool converge into the procurement decisions that will define the region's water infrastructure for the next thirty years. Microvi is committed to being a substantive part of that conversation — with operational data, transparent performance, and technology that meets the next nitrogen limit at a footprint and cost the region can actually afford.

Stanfield, Arizona is a small rural community facing a difficult drinking water reality: groundwater contaminated with elevated nitrate and arsenic, two contaminants that conventional treatment technologies typically address through expensive, energy-intensive, and waste-generating processes. For a rural utility, those costs translate directly into either unaffordable rate increases or sustained non-compliance.

Arizona Water Company, in partnership with Microvi Biotech, has been awarded $9.1 million in funding from the United States Bureau of Reclamation's WaterSMART program. The award supports the Stanfield Groundwater Supply and Treatment Project — a critical initiative to address nitrate and arsenic contamination and ensure clean, safe drinking water for the community.

The project will deploy Microvi's MNE™-based biological nitrate treatment alongside arsenic removal technology, providing Stanfield with a treatment train that is fundamentally more cost-effective to operate than the conventional alternative. WaterSMART funding offsets the capital cost of bringing this technology online, addressing the affordability barrier that has historically prevented rural and disadvantaged communities from accessing the best available treatment options.

The Stanfield project is part of a broader pattern: federal funding programs are increasingly recognizing that the communities most affected by groundwater contamination are often the least able to afford conventional treatment, and that next-generation biological approaches change that calculus.

The Water Environment Federation (WEF) Innovation in Treatment Technology Conference is one of the most influential gathering points for the global wastewater treatment community — bringing together the utility leaders, design engineers, regulators, and technology providers who collectively shape where the industry goes next.

Microvi will present its breakthrough nutrient removal solutions at the conference, with focus on the MNE™-based approaches to nitrogen and phosphorus removal that have now been operationally validated across deployments in the US, UK, and EU. Microvi's portfolio includes anammox-based ultra-low nitrogen removal, biological phosphorus mineralization, and integrated biofertilizer recovery pathways that convert wastewater nutrient streams into agricultural inputs.

Conference participation is a core part of how Microvi engages with the operational and engineering community that ultimately decides which technologies move from interesting to deployed. We look forward to the conversations, the technical exchanges, and the partnerships that come out of WEF every year.

Across spring 2024, Microvi participated in a series of high-profile environmental and water treatment conferences — opportunities to share operational results, engage with the broader water community, and advance partnerships that turn technology into deployments.

Featured technology demonstrations and discussions included nutrient removal pathways for both wastewater and drinking water applications; hexavalent chromium (Cr(VI)) remediation following Microvi's NIEHS program; advanced wastewater treatment integrations combining biological nitrogen removal with carbon diversion; and emerging environmental remediation applications including PFAS, arsenic, and nitrate.

These engagements highlight Microvi's commitment to advancing sustainability and environmental health through the deployment of next-generation biotechnologies — and the substance of the technical exchanges with utility operators, regulators, and engineering firms is consistently what drives the next round of deployments.

Three years ago, Microvi commissioned a sidestream nitrogen removal system at Oro Loma Sanitary District in the San Francisco Bay Area. At the time, the deployment was a frontier demonstration of what an MNE™-based biological treatment train could deliver in continuous operational service.

Three years later, the system has delivered consistent, high-performance sidestream nitrogen treatment — meeting Oro Loma's process requirements, integrating cleanly with the rest of the facility, and operating at the kind of footprint and energy profile that the Bay Area's emerging nutrient regulations will increasingly require.

The collaboration between Microvi, Oro Loma Sanitary District, and HDR is a model for how operational utility partnerships, engineering firms, and technology providers can together advance the practice of wastewater treatment. The Oro Loma site has become a reference point that Microvi customers, partners, and regulators routinely visit to understand what a modern biological nitrogen removal system looks like in continuous service.

Three years in, the system is delivering what it was designed to deliver — and the data is publicly available for utilities evaluating their own nutrient compliance pathways.

Ofwat's Water Discovery Challenge is one of the UK water sector's most consequential innovation programs — designed to identify, validate, and scale breakthrough technologies that can deliver step-change benefits to customers, communities, and the environment. The competition is delivered in partnership with Challenge Works, Arup, and Isle Utilities.

Microvi Biotech and Cranfield University have been jointly selected as winners of the Water Discovery Challenge for their Bio-Mineral Phosphorus Removal (BMPR) technology — a coagulant-free biological approach to phosphorus removal and recovery that achieves industry-leading performance while producing a valuable mineral product instead of inert chemical sludge.

Winning the Discovery Challenge unlocks both funding and structured access to the UK's largest water companies — a pathway from research-stage technology to operational demonstration that has historically been difficult for innovators to navigate alone. For Microvi and Cranfield, the win is the foundation for the program of demonstrations now advancing through Severn Trent and other UK water companies.

More broadly, the recognition reinforces a position Microvi has held since the company's founding: that the highest-performance environmental technologies of the next decade will not be incremental improvements on the chemical approaches of the last century — they will be biological.

Xenobiotics — environmental toxins introduced into the body through food, water, and broader environmental exposure — represent one of the more complex public-health challenges of the next decade. Arsenic in drinking water is among the most consequential examples: an exposure pathway that affects millions of people globally, with health impacts that conventional water treatment alone cannot fully address.

Nexilico has been awarded funding from the National Institutes of Health (NIH) to advance microbiome-based solutions for xenobiotic detoxification, in partnership with UC Berkeley and Microvi Biotech. The program will leverage the transformative biological capacity of the gut microbiome to detoxify environmental toxins — with initial focus on arsenic, one of the most dangerous and widespread environmental toxins affecting communities worldwide.

Microvi's contribution to the program draws on its extensive expertise in encapsulating, stabilizing, and deploying microbial consortia for environmental applications. Translating that platform from external treatment systems to internal microbiome-based interventions is a significant scientific and engineering challenge — and the NIH-funded collaboration is the rigorous, multi-institution program designed to address it.

The convergence of environmental microbiology, water treatment, and human health represents one of the more promising frontiers in addressing the cumulative impact of environmental contamination — and Microvi is proud to be part of the work.

The US Environmental Protection Agency's Administrator's Award recognizes contractors whose work has delivered exceptional value to EPA programs and to the broader public mission the agency serves. The award is given selectively, and it represents a significant recognition for small businesses contributing to environmental protection through scientific and engineering work.

Microvi Biotech Inc. has been awarded the EPA Administrator's Award for Outstanding Accomplishments by a Small Business Contractor — recognition of years of EPA-supported research, demonstration, and deployment of biological treatment technologies addressing the most complex contaminants in the US water sector.

Across the EPA partnership, Microvi has advanced technologies addressing hexavalent chromium, nitrate, perchlorate, and other priority contaminants — moving each from research-stage demonstration to operationally validated treatment systems serving real communities.

We are deeply grateful for the recognition, and for the long-term partnership with EPA that has been instrumental in bringing Microvi's biological treatment platform to the communities that need it most.

Climate change is creating sustained uncertainty in future water supplies across the American Southwest. Population growth is driving continuously increasing demand. Together, those forces have made the future of drinking water a defining infrastructure challenge for cities across Arizona and the broader region.

Microvi and the City of Goodyear have unveiled Arizona's first groundwater biological nitrate treatment system — a commercial-scale deployment of Microvi's MNE™ platform delivering millions of gallons of safe, compliant drinking water from groundwater that had previously been compromised by nitrate contamination.

Goodyear's investment in biological nitrate treatment reduces the city's risk exposure on multiple dimensions simultaneously: it protects access to a local groundwater resource that would otherwise have been written off, it does so at a per-volume operating cost dramatically lower than ion exchange or reverse osmosis, and it does so without generating brine waste that itself becomes a costly disposal problem.

The Goodyear deployment is now operational and serving the community. For other cities across the Southwest grappling with the same nitrate-and-supply pressure, the system is a working reference for what biological drinking water treatment can deliver at commercial scale.

The global challenge of nutrient removal — nitrogen, phosphorus, and the operational and regulatory pressures that come with both — requires the kind of sustained, operational R&D infrastructure that is genuinely difficult to assemble. It needs continuous access to representative wastewater streams. It needs co-location with utility partners who can host pilot trains. And it needs the scientific and engineering bench depth to keep multiple programs advancing in parallel.

Microvi has inaugurated its Wastewater Innovation Center at the Hayward Water Pollution Control Facility (HWPCF) — a collaboration with the City of Hayward that gives Microvi continuous on-site access to real municipal wastewater, embedded within a fully operational treatment facility.

The Innovation Center serves as the operational base for Microvi's wastewater R&D portfolio: pilot trains for emerging customer programs, long-duration validation studies for new MNE™ formulations, and the kind of sustained side-by-side comparisons against conventional treatment that move technology from research-stage to deployment-ready.

The collaboration with HWPCF is also a model for how municipal utilities and technology innovators can work together at the scale and pace the sector needs. We are deeply grateful for the partnership.

Hexavalent chromium (Cr(VI)) is one of the most consequential drinking-water contaminants of the present decade. It is a known carcinogen. It is widely distributed across groundwater sources in California and beyond. And the conventional treatment options — ion exchange, reverse osmosis — are expensive, generate concentrated waste streams, and are particularly difficult for smaller utilities to deploy.

Microvi has been awarded over $1.1 million in funding to scale its new MNE™-based biological technology for the elimination of hexavalent chromium in drinking water — bringing a fundamentally more affordable treatment pathway closer to commercial deployment for the communities that most need it.

"We are excited to finalize this new technology for such a significant problem that affects the health of millions of people around the globe," said Dr. Fatemeh Shirazi, CEO of Microvi. "Our commitment to our customers in the drinking water industry has always been to offer the most reliable, advanced, safe, and cost-effective treatment technologies."

Scaling the chromium platform is part of Microvi's broader drinking water portfolio addressing nitrate, arsenic, chromium, and other priority groundwater contaminants — all built on the same MNE™ biocatalyst platform, and all engineered to bring high-performance treatment to communities that have historically been priced out of it.

California's drinking water supply is under sustained pressure from population growth, climate variability, and persistent groundwater contamination — particularly nitrate. For utilities, every gallon of groundwater that can be safely treated and delivered to households is a gallon that does not need to be imported, desalinated, or otherwise procured at significantly higher cost.

Microvi has achieved a major commercial milestone at the Sunny Slope Water Company in Pasadena, California — where its MNE™-based biological nitrate treatment system has been continuously operating, consistently verified by stringent independent water quality testing, and delivering clean, compliant drinking water to tens of thousands of households served by the utility.

"Sunny Slope Water Company has attracted visitors from all over the world to see Microvi's system in action," said Ken Tcheng, General Manager of Sunny Slope Water Company. "Microvi's high-performance system has been consistently verified by stringent water quality testing. Tens of thousands of households in our service area have been able to enjoy clean water and low costs offered by the Microvi system at Sunny Slope Water Company."

The Sunny Slope deployment has since been featured as a primary case study in the AWWA Manual M80 on Biological Drinking Water Treatment — establishing it as a foundational operational reference for the broader US drinking water industry.

Microvi has successfully commissioned its MNE™ nutrient removal technology at the Linda County Water District as part of a $6.5 million project funded by the California Energy Commission. The project, led by Caliskaner Water Technologies (CWT), is demonstrating the operational and economic benefits of an integrated, intensified secondary wastewater treatment approach.

"It has been effortless working with the Microvi team to implement their system and successfully commission their component of this groundbreaking project," said Onder Caliskaner, President of CWT and Principal Investigator of the project.

The Linda installation is one of the highest-profile demonstrations of MNE™-based biological treatment in the United States — combining advanced primary treatment with biological nitrogen removal in a single integrated train, at a footprint and energy profile that conventional activated-sludge platforms cannot match.

The commissioning marks the start of multi-year operational data collection that will inform the next generation of wastewater facility upgrades across California.

Microvi has opened a new office and research facility in Michigan — marking the company's first U.S. expansion beyond its San Francisco Bay Area headquarters. The new facility accommodates rapid growth in the team, leverages the region's diverse high-technology talent pool, and supports the increasing demand for Microvi projects across the Midwest and East Coast.

Michigan offers proximity to a deep pool of biological, chemical, and environmental engineering talent, as well as a strategic location for serving the Great Lakes water utilities and the broader Midwestern industrial base. The expansion reflects sustained commercial momentum across Microvi's portfolio — from drinking water nitrate treatment to industrial bioprocessing and grant-funded R&D programs.

The Hayward, California headquarters remains the company's primary R&D, manufacturing, and commercial hub. The Michigan facility extends that capacity into a new region while maintaining the close integration that has defined Microvi's operational model.

The City of Goodyear, Arizona has awarded Microvi a contract for Arizona's first commercial biological nitrate treatment plant — a milestone deployment that will deliver safe, affordable drinking water to the city using Microvi's MNE™ biocatalyst platform.

"We're excited to introduce this innovative technology to our drinking water treatment system," said Barbara Chappell, Goodyear Public Works Deputy Director. "The Microvi system has exceeded our treatment goals while providing an economical and environmentally friendly operation."

The Goodyear deployment validates the regional case for biological nitrate treatment across the American Southwest — where groundwater nitrate contamination, climate-driven supply pressure, and the high cost of conventional ion-exchange or reverse-osmosis treatment converge into a compounding challenge for utilities.

Microvi's system at Goodyear became the foundational reference deployment that subsequently informed similar projects across Arizona and the broader region, including the WaterSMART-funded Stanfield project announced in 2024.

Wessex Water, one of the UK's major regional water utilities, has completed a successful demonstration of Microvi's MNE™ technology for tertiary nitrate removal from secondary-treated effluent — operating at the low temperatures that define the UK winter operating envelope and represent the most challenging conditions for biological nitrogen treatment.

The demonstration follows Wessex Water's 2021 evaluation of MNE™ for tertiary ammonia removal at the same site — extending the technology validation across both ends of the nitrogen treatment cycle. Together, the two campaigns establish MNE™ as a credible candidate for utilities pursuing ultra-low effluent nitrogen targets without major capital reconstruction.

Low-temperature biological treatment has long been a structural limitation of conventional activated-sludge nitrogen removal — the underlying biology slows substantially below 10°C. MNE™'s encapsulated, high-density biological matrix is structurally better suited to the operating conditions UK utilities face for much of the year.

Microvi, in collaboration with Severn Trent and Cranfield University, has been selected as a winner in Ofwat's Water Breakthrough Challenge — receiving £762,447 ($1,005,736) in funding to advance MNE™-based biological ammonia removal that eliminates the formation of nitrous oxide (N₂O), a greenhouse gas approximately 300 times more potent than CO₂.

Nitrous oxide emissions from conventional biological nitrogen removal are one of the wastewater sector's most consequential and least-addressed climate liabilities. Most facilities emit N₂O continuously as a byproduct of the nitrification-denitrification process — typically uncontrolled, often unmeasured, and increasingly part of the regulatory and reputational accounting framework that utilities will be expected to manage.

The Ofwat program funds the development and demonstration of Microvi's biological approach to ammonia removal that fundamentally avoids the N₂O formation pathway — a capability the broader sector has been actively seeking. Severn Trent provides the operational utility context; Cranfield University provides the academic and analytical rigor; Microvi provides the platform technology.

The award marks the start of a multi-year program that has since matured into Microvi's commercial Nanovi™ GHG-elimination product line.

Microvi has announced the commercial availability of its packaged nitrate treatment plants for drinking water — a complete, factory-built, drop-in treatment train that consolidates years of operational validation into a deployable product.

The system features a stainless steel reactor housing the MNE™ biocatalysts for nitrate removal, followed by an ultrafiltration membrane system and a disinfection train that together polish the reactor effluent for potable use. The plant is controlled via an automated system programmed for exact chemical dosing based on incoming nitrate levels and online nitrate sensing.

Remote control capabilities mean the system can be operated with minimum on-site operator interference — a meaningful operational advantage for small and mid-sized utilities that often lack the technical staffing depth of larger municipal systems.

The packaged plant format dramatically reduces the engineering, procurement, and commissioning timeline for utilities pursuing nitrate compliance — converting what has historically been a multi-year custom-build project into a months-long deployment.

Microvi and the Oro Loma Sanitary District (OLSD) have celebrated the grand opening of the first full-scale sidestream wastewater treatment system in the U.S. Western Region. The system uses Microvi's MNE™ technology to treat the high-strength nitrogen returning from dewatering — a stream that historically loops back into the front of the treatment plant and dominates the facility's nitrogen mass balance.

"The project team came together to design a minimalist process, using an existing tank and repurposed blower," said Jason Warner, Oro Loma General Manager. "It is a testimony to the simplicity of the Microvi process and our operations team that we have achieved such great treatment results."

The Oro Loma installation became one of the most important reference points for Bay Area utilities preparing for the next generation of San Francisco Bay nitrogen discharge regulations — demonstrating that meaningful nitrogen removal can be achieved using existing infrastructure, retrofitted with biological technology, rather than through ground-up plant reconstruction.

The system has since operated continuously and was the basis for Microvi's three-year operational anniversary announcement in 2024.

Microvi has been selected to participate in a $6.5 million California Energy Commission project led by Caliskaner Water Technologies (CWT) at the Linda Water Resource Recovery Facility in Linda, California. The program will demonstrate the integrated performance and economic benefits of advanced wastewater treatment technologies — combining MNE™ biological nitrogen removal with advanced primary treatment in a holistic system.

The Linda program represents one of the most ambitious operational demonstrations of integrated next-generation wastewater treatment in California. The goal is to validate, at full scale and over multi-year operating periods, that low-carbon, low-footprint, chemical-free nitrogen removal is operationally achievable — not just experimentally feasible.

Microvi's contribution centers on the biological nitrogen removal step, where MNE™ delivers compact, energy-efficient treatment without the chemical dosing or biosolids generation that conventional approaches require. The program is now operationally underway and has subsequently produced the breakthrough results announced in 2025.

Microvi's cost-effective MNE™ nitrate treatment system is delivering safe, clean drinking water to rural communities in California's Central Valley — including a project in Modesto carried out in partnership with Elemental Excelerator's Equity and Access track.

"We're big believers in the solutions Microvi develops to help communities deliver safe, clean drinking water, and seeing these results in Modesto validate our beliefs," said Kim Baker, Director of Innovation at Elemental Excelerator. "As climate challenges continue to impact the water supply, it's critical that these technologies are adopted by the marketplace to ensure equitable access to drinking water everywhere."

Rural Central Valley communities sit at the intersection of California's most persistent groundwater nitrate contamination and the state's least-resourced water utilities. The cost gap between conventional nitrate treatment and what these communities can afford has historically translated directly into sustained regulatory non-compliance — and into health outcomes that disproportionately affect low- and moderate-income households.

Microvi's biological approach changes that economics. The Modesto project is one of several deployments demonstrating that the technology is operationally and financially viable at the scale Central Valley communities actually need.

The National Institutes of Health (NIH) has awarded funding to a collaborative program between Microvi, Nexilico, and UC Berkeley to develop a computational platform for predicting how the human gut microbiome influences drug efficacy and toxicity.

Microbial metabolism of pharmaceutical compounds is one of the most consequential and least-understood factors in drug efficacy and adverse outcomes. The gut microbiome can dramatically alter the bioavailability, activation, and toxicity profile of an administered drug — and current pharmaceutical development pipelines have only limited tools for accounting for that effect at scale.

The collaboration combines Nexilico's machine learning and microbiome modeling capabilities with Microvi's MNE™ platform for experimental validation and UC Berkeley's academic depth in microbial biology. The output: an in silico solution, supported by rigorous wet-lab validation, that can reliably identify and characterize microbial metabolism of drug compounds.

For Microvi, the program extends the company's MNE™ platform into a frontier application — pharmaceutical and microbiome science — where the same encapsulation and biological control capabilities that drive water and wastewater treatment can support a fundamentally different category of research.

Wessex Water has been operating a Microvi MNE™ demonstration plant at one of its treatment facilities in Southwest England since March 2021, as part of the utility's evaluation of advanced nitrogen treatment technologies to support its AMP7 (Asset Management Plan) regulatory strategy.

The AMP cycle is the structural mechanism through which UK water companies plan and fund five-year capital and operational programs in alignment with regulatory targets. AMP7 — covering 2020 to 2025 — placed an increased emphasis on nutrient removal, environmental discharge limits, and the technologies needed to achieve them.

The MNE™ demonstration plant was initially tested for tertiary ammonia removal under winter operating conditions, with successful results. The program then extended into nitrate reduction testing through the summer months — covering both ends of the nitrogen treatment cycle and both extremes of the UK temperature envelope.

The Wessex Water relationship has since extended into the additional low-temperature nitrate work announced in 2022.

The City of San Juan Bautista, California has restored its critical community drinking water supply through the deployment of a Microvi MNE™ treatment system — addressing persistent groundwater nitrate contamination that had compromised the city's water security.

Nitrate is one of the most widespread contaminants in groundwater globally, and its human health impacts — including methemoglobinemia in infants and elevated cancer risk in adults — are disproportionately felt in rural communities where groundwater contamination with agricultural runoff is pervasive.

For San Juan Bautista, the Microvi system provides a permanent treatment solution where blending with non-contaminated sources is not economically or geographically viable. The system delivers continuous nitrate removal at operating costs the city can sustain, restoring the community's local groundwater resource as a viable drinking water supply.

The deployment is part of Microvi's broader portfolio of community-scale drinking water installations across California — a portfolio that has now expanded to include the AWWA Manual M80-featured Sunny Slope system, the Goodyear Arizona deployment, and the WaterSMART-funded Stanfield project.

Microvi has announced a strategic collaboration with Murraysmith + Quincy — a major US engineering firm specializing in water and wastewater infrastructure — to extend the deployment of Microvi's MNE™ solution to a broader set of US communities facing drinking water compliance challenges.

With contaminants such as ammonia, nitrate, perchlorate, chlorinated solvents, 1,4-dioxane, and other emerging compounds threatening public health and environmental sustainability across the US, water engineers need to embed water treatment infrastructure with affordable and reliable purification technology. Murraysmith + Quincy brings the engineering, design, and project delivery capacity required to translate Microvi's platform into deployed treatment trains at scale.

Engineering-firm partnerships are one of the most consequential commercial accelerators available to a technology provider in the water sector. The procurement, design, and specification decisions that ultimately determine which technologies reach deployment are typically made by engineering consultants on behalf of their utility clients — and a strong working relationship with a firm like Murraysmith + Quincy reshapes that pipeline.

Microvi and FLI Water (FLI) have formed an exclusive partnership covering the United Kingdom and Ireland. The agreement combines Microvi's MNE™ biological treatment platform with FLI's regional engineering, fabrication, and project delivery capability — providing turnkey end-to-end solutions for both industrial and municipal wastewater customers.

The UK and Ireland water sectors are structurally well-suited to Microvi's technology. Regulatory pressure on nitrogen and phosphorus discharge limits is sustained; the operating temperature profile favors biological systems engineered for low-temperature performance; and the regulated structure of the UK water industry (through Ofwat and the AMP cycle) creates a clear capital-planning environment for new technology adoption.

FLI's regional presence and engineering depth complement Microvi's platform technology, giving UK and Irish customers a single integrated provider capable of taking a project from initial assessment through commissioning and operations. The partnership has since supported multiple UK water company evaluations and deployments.

Microvi and the Oro Loma/Castro Valley Sanitary Districts (OLSD/CVSan) have commissioned the first commercial dewatered filtrate (sidestream) treatment system in the U.S. Pacific Coast Region — at OLSD's 12 million-gallon-per-day (MGD) treatment plant in San Lorenzo, California.

The full-scale system uses Microvi's MNE™ technology to remove nitrogen from the high-strength filtrate returning from sludge dewatering — reducing OLSD's nitrogen discharge to the San Francisco Bay by up to 400,000 pounds per year. The deployment is part of the broader Bay Area effort to reduce nutrient loading to the Bay ahead of the regulatory transition that is reshaping the region's wastewater infrastructure.

Sidestream nitrogen treatment is one of the highest-leverage interventions available to a utility: the volumetric flow is small relative to the main plant, but the nitrogen mass is disproportionately high. Treating it once, at the side, often delivers more nitrogen mass removal than equivalent capital investment in the main treatment train.

The OLSD/CVSan commissioning represented a major operational milestone for the Bay Area and a structural validation of MNE™ at full commercial scale.

Microvi has announced unprecedented results from its NIH-funded program for biological hexavalent chromium (Cr(VI)) removal — demonstrating both treatment efficacy and operating cost reduction at levels not previously achieved by any technology on the market.

Conventional Cr(VI) treatment relies on ion exchange or reduction-coagulation-filtration — both of which carry significant capital, operations, and waste-handling costs that have priced compliance out of reach for many smaller utilities. Microvi's biological approach reduces Cr(VI) to its non-toxic trivalent form (Cr(III)) using MNE™-encapsulated organisms, achieving the same compliance outcome at a fraction of the operating cost and without generating concentrated brine waste streams.

The combination of treatment efficacy and operating cost reduction marks the first time both objectives have been met simultaneously by a commercially-relevant Cr(VI) treatment technology. The results announced in March 2021 launched the multi-year program that ultimately concluded with the successful NIEHS program completion announced in January 2026.

The chromium platform is now positioned for commercial deployment across California's Cr(VI) compliance landscape and at industrial remediation sites carrying legacy chromium contamination.

Microvi has been awarded $1.12 million in funding from the National Institutes of Health (NIH) to develop precision biological processes that combine the MNE™ platform with machine learning and bioinformatics — pushing the underlying science of biological treatment from empirical observation toward computational prediction.

The project pairs Microvi's MNE™ platform with Nexilico's machine learning and microbiome modeling platforms. The output: a computational framework capable of predicting which microorganisms are optimal for a given water treatment application, driving the development of more targeted biological solutions, and increasing the reliability and success rate of how those solutions are deployed in operational systems.

Precision biology has the potential to transform water treatment in the way precision agriculture transformed farming and precision medicine is transforming healthcare. The same fundamental shift — from empirical, one-size-fits-many approaches to data-driven, application-specific design — applies to biological water treatment with particular force, because the underlying biology is highly sensitive to influent chemistry, temperature, and operating conditions.

The NIH-funded program is one of the foundational pillars of Microvi's R&D portfolio in biological process intelligence.

Microvi has celebrated multiple years of successful operation of its commercial MNE™ nitrate treatment system, with operational performance now demonstrably outperforming the original economic projections.

Initial estimates predicted 50% savings in operational costs compared to conventional treatment alternatives. Recent data analysis confirms that the actual operational cost savings have reached 75% — a structural advantage that compounds over the multi-decade operating life of a water treatment system.

Just as importantly, the system has validated a defining advantage of Microvi's sustainable biology approach: little or no biological waste has been produced over more than 48 months of continuous operation. Conventional nitrate treatment alternatives generate either concentrated brine (ion exchange, reverse osmosis) or biological sludge — both of which carry significant downstream disposal cost and environmental burden.

The multi-year operational record now sits as one of the highest-quality public-data references available for biological nitrate treatment in commercial drinking water service.

Microvi has signed a tripartite agreement with Severn Trent — one of the UK's largest regulated water companies — and Cranfield University, one of the UK's leading academic centers for water research, to collaborate on a circular economy initiative focused on recovering nutrients from wastewater for reuse in agriculture and other industries.

Nutrient recovery represents one of the most consequential and least-realized opportunities in the wastewater sector. Phosphorus and nitrogen — both essential agricultural inputs — are present in wastewater in substantial quantities, but the conventional treatment paradigm treats both as contaminants to be removed and discarded rather than resources to be captured and circulated.

The Severn Trent–Cranfield–Microvi collaboration is designed to bridge that gap. By combining utility-scale operational context, academic depth in nutrient chemistry, and Microvi's MNE™ platform for biological mineralization, the partnership advances both the science and the practical engineering of nutrient recovery at deployable scale.

The agreement laid the foundation for the subsequent BMPR work that ultimately won Ofwat's Water Discovery Challenge and is now operating at the Severn Trent Minworth facility.

Microvi has expanded its reach into the areas of California most affected by nitrate pollution — partnering with the City of Modesto and Elemental Excelerator to demonstrate autonomous nitrate treatment system capabilities for Central Valley communities.

California's Central Valley sits at the intersection of the state's most productive agricultural region and its most persistent groundwater contamination. Decades of fertilizer application and historical land use have produced sustained, slowly migrating nitrate contamination across many of the aquifers that rural Central Valley communities depend on for drinking water.

The Modesto deployment demonstrates that Microvi's MNE™ platform can be packaged as an autonomous, low-supervision treatment unit suitable for small and mid-sized rural utilities — a configuration that is structurally difficult to achieve with conventional ion exchange or reverse osmosis systems.

Elemental Excelerator's Equity and Access track provides funding designed specifically to bring clean water technology to the communities that have historically been priced out of it. The Microvi–Modesto deployment is one of the most direct examples of that mission translating into operational drinking water service.

Microvi has received significant funding to scale high-throughput manufacturing of its MNE™ technologies — a structural investment in the company's manufacturing infrastructure designed to support accelerated global commercialization.

The funding supports the integration of specialized, high-throughput equipment that optimizes material usage, reduces labor requirements, and enables liquid and chemical recycling within the manufacturing process. Together, these investments improve both the unit economics of MNE™ production and the sustainability profile of the manufacturing operation itself.

Manufacturing capacity is one of the more frequently underestimated dimensions of scaling a deployed technology. The transition from laboratory to commercial scale demands not just a working product but a manufacturing system that can produce that product reliably, repeatably, and economically at the volumes the commercial pipeline requires.

The high-throughput manufacturing investment supports Microvi's continued expansion across water, wastewater, and emerging industrial bioprocessing markets globally.

The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, has awarded Microvi a grant to develop a new biological technology for hexavalent chromium (Cr(VI)) treatment — addressing a contaminant that affects millions of people across the United States and globally.

Hexavalent chromium is a known human carcinogen. California has adopted a 10 ppb maximum contaminant level (MCL), and other states are evaluating similar standards. The conventional treatment toolkit — primarily ion exchange and reduction-coagulation-filtration — works, but at a capital and operating cost that has structurally limited deployment, particularly for smaller water systems.

Microvi's biological approach uses MNE™-encapsulated microorganisms to reduce Cr(VI) to its non-toxic trivalent form (Cr(III)), achieving the regulatory outcome without the brine waste, energy demand, or capital intensity of conventional alternatives.

This 2020 NIEHS grant launched the multi-year program that produced the breakthrough operational results announced in 2021 and ultimately concluded with the successful program completion announced in January 2026 — moving the chromium platform from research-stage to commercial-ready.

Microvi has been awarded funding to demonstrate the intensification of the activated sludge process for biological phosphorus capture and nitrogen removal — extending the MNE™ platform's applicability into the most widely deployed wastewater treatment technology in the world.

The activated sludge process is the workhorse of global wastewater treatment. Hundreds of thousands of municipal and industrial facilities operate variants of activated sludge, and the engineering, operational, and regulatory practice of the global water sector is built around it.

Intensifying that process — increasing the treatment capacity and effectiveness per unit of physical infrastructure — is one of the highest-value upgrades available to the existing global wastewater treatment fleet. It allows utilities to meet tightening discharge limits and accommodate population growth without the capital cost and disruption of fundamentally rebuilding their plants.

Microvi's MNE™ platform supports activated sludge intensification by embedding high-density encapsulated biology into the existing process — increasing biological capacity, treatment rate, and removal efficiency simultaneously. The funded trial advances that capability toward commercial-scale demonstration.

Microvi's MNE™ technology has outperformed the established tertiary ammonia removal process at a Thames Water wastewater treatment plant in the United Kingdom — operating reliably across the full temperature range of 5°C to 22°C and consistently exceeding the ammonia removal rates of the existing nitrifying sand filters.

Thames Water is the United Kingdom's largest water and wastewater utility, serving roughly 15 million customers across London and the Thames Valley. Trial outcomes at Thames Water carry significant weight in the broader UK water sector's evaluation of new technology.

The Thames demonstration validates two structural advantages of the MNE™ platform: first, its ability to outperform an already-installed conventional tertiary treatment process at the same site under operational conditions; and second, its temperature resilience — sustained performance across both the warm summer and cold winter operating envelope that defines UK conditions.

The Thames Water relationship subsequently informed the broader portfolio of MNE™ evaluations across multiple UK water companies.

Microvi and Nexilico, with funding from the National Institutes of Health (NIH), have developed a powerful computational platform for modeling the human gut microbiome and its effects on drug efficacy and toxicity.

The in silico platform is designed to reduce the cost and timeframe of pharmaceutical drug development by reducing the need for iterative pre-clinical experiments — and by better directing the design of clinical trials when they do proceed. The platform simultaneously increases the effectiveness of the therapeutics themselves by accounting for microbiome-driven metabolic effects that conventional pre-clinical models often miss.

The NIH-funded program is one strand of a broader Microvi–Nexilico collaboration that extends from environmental biology into human health applications. The platform technology shares conceptual DNA with Microvi's MNE™ environmental biology work: in both domains, the goal is the design and prediction of microbial system behavior at a level of precision that conventional empirical approaches cannot reach.

This program is the foundation of the subsequent 2021 NIH expansion announced for drug efficacy and toxicity prediction.

Microvi has received the 2020 Institute of Water Scottish Region Innovation Award — recognition from the UK water sector's professional institute for the operational impact of Microvi's MNE™ technology following multi-year demonstrations at Scottish Water.

In 2019 and 2020, Microvi completed a series of large-scale demonstrations of MNE™ at Scottish Water's Wastewater Development Centre at the Bo'ness Treatment Works. The demonstrations covered both ammonia removal and biochemical oxygen demand (BOD) removal — two of the most consequential operational parameters for any wastewater treatment facility.

The Institute of Water is the UK's professional body for the water sector, and the Scottish Region Innovation Award recognizes technology contributions that have advanced the practice of water treatment in Scotland and the broader UK. The award validates not just the technology itself, but the credibility of Microvi as an operational partner to one of the UK's regulated water utilities.

The Scottish Water relationship has since informed Microvi's broader engagement across the UK water sector, including the subsequent Wessex Water, Thames Water, South West Water, and Severn Trent programs.

Microvi has announced a breakthrough application of its MNE™ technology for low-cost water reuse in agriculture — specifically targeting the fresh-cut produce industry, one of the largest agricultural users of water with significant potential for water reuse.

Given constraints on freshwater availability in agricultural regions, the food industry faces sustained pressure to adopt sustainable water practices through water reuse. Wash water from fresh-cut produce operations is a particularly high-value reuse target: it represents enormous water volumes, it has clearly characterized chemistry, and it has consistent quality requirements driven by food safety considerations.

MNE™ leverages engineered biocatalysts to safely and rapidly reduce the levels of dissolved organic and inorganic compounds in wash water under very low temperatures — without contributing solids or secondary wastes to the wash water stream itself. This combination is structurally difficult to achieve with conventional treatment approaches, which typically either operate poorly at low temperatures or generate secondary waste streams that themselves require management.

The application opens an addressable market that combines agricultural sustainability, food safety, and water reuse — all of which are operationally and economically aligned with the underlying MNE™ platform capability.

Microvi's MNE™ technology has been selected for the San Francisco Bay Area's first full-scale wastewater sidestream treatment system — a multi-million-dollar collaborative project at the Oro Loma Sanitary District (OLSD) in San Lorenzo, California. The project is funded by the US Environmental Protection Agency (EPA).

The deployment is a collaboration between Microvi, OLSD, engineering firm HDR Inc., and project design engineer EKI Environment and Water Inc. Together, the team is installing a Microvi MNE™ sidestream system at OLSD's 20 MGD treatment plant — designed to reduce the high-strength nitrogen load returning from sludge dewatering, which dominates the facility's overall nitrogen mass balance.

The Bay Area is on the leading edge of the next generation of US nutrient discharge regulation. The San Francisco Bay receives nitrogen discharge from dozens of wastewater facilities across the region, and the regulatory transition now underway will require many of those facilities to significantly reduce their nitrogen load.

OLSD's investment in sidestream treatment is one of the most cost-effective interventions available — and the EPA-funded Microvi deployment is the first full-scale validation of that approach in the Bay Area.

Scottish Water has completed a successful demonstration of Microvi's MNE™ technology for ammonia and biochemical oxygen demand (BOD) removal — confirming operational performance that, in several dimensions, fundamentally outperforms conventional wastewater treatment technologies including the activated sludge process that dominates the global wastewater sector.

The demonstration results confirmed that MNE™ can treat ammonia and soluble BOD to below detection limits even at high flow and high organic loading conditions. Under normal operating parameters, the effluent consistently achieved below 1 mg/L ammonia — with hydraulic retention times (HRT) of approximately 4 hours.

The 4-hour HRT is roughly half the retention time of comparable conventional technologies. For a utility, that translates directly into either roughly half the reactor volume needed to treat a given flow, or roughly double the treatment capacity from a given existing footprint. Either outcome represents a significant structural advantage in capital planning.

Scottish Water's Bo'ness facility has been one of the most rigorous and well-instrumented operational test environments for biological treatment technology in the UK water sector. The Bo'ness results have become a reference point for MNE™'s performance characterization globally.

Microvi has been recognized as a 2019 Technology Pioneer by the World Economic Forum — one of the most prestigious global recognitions available to an emerging technology company, identifying organizations whose innovation has the potential to significantly impact business and society.

"To receive this prestigious acknowledgement as a 2019 Technology Pioneer by the World Economic Forum is a great honour," said Microvi's CEO Dr. Fatemeh Shirazi. "It is confirmation of the impactful work we are doing to provide safe and equal access to water, our drive towards a sustainable environment, and improving the lives of many people worldwide."

The Technology Pioneer program identifies a global cohort of emerging companies each year that the World Economic Forum views as positioned to drive systemic change. Past cohorts have included organizations that subsequently became defining infrastructure of their respective industries.

For Microvi, the recognition placed the company on a globally visible stage at a pivotal moment in its commercial trajectory — and helped catalyze the international relationships, partnerships, and customer engagements that have shaped the subsequent years of growth.

Microvi has announced the successful development of its MNE™ platform technology for the treatment of process wastewater from ethanol production facilities — extending the company's footprint into bioethanol manufacturing, one of the largest industrial wastewater generators in the agricultural processing sector.

Ethanol plants generate substantial process wastewater volumes characterized by high organic loading and consistent compositional patterns. Conventional treatment is energy-intensive, generates significant biosolids, and typically leaves the treated water unsuitable for direct reuse — driving the facility to procure additional fresh water for its production cycle.

MNE™ changes the economics on both sides: it demands less energy and reduces operating costs while simultaneously producing a treated water quality sufficient to support meaningful water reuse within the plant's own production loop. For an ethanol facility in a water-constrained region, that combination is structurally valuable.

The application opens an addressable market that aligns the underlying MNE™ platform with the operational and economic priorities of one of the largest industrial wastewater categories in the bioeconomy.

Microvi has been named Breakthrough Technology Company of the Year at the 2019 Global Water Awards in London — the highest annual recognition available in the international water industry.

Established in 2006 by Global Water Intelligence — the leading commercial intelligence publication for the global water sector — the Global Water Awards recognize the most important achievements across the international water industry. Categories cover the full water cycle, and the Breakthrough Technology Company of the Year designation specifically recognizes the organization whose technology has had the greatest disruptive impact on the industry over the preceding year.

The award is determined by a global jury of senior water industry executives, technology providers, utility leaders, and regulators — making it one of the most peer-validated recognitions available in the sector.

For Microvi, the recognition placed the company at the front of the international water technology conversation — and accelerated the operational, commercial, and capital relationships that have shaped the company's subsequent global expansion.

Microvi has received the Bio-Based Chemical Innovation of the Year Award from World Bio Markets Insights — recognition of the company's contributions to the bio-based chemicals and fuels sector during the 4th annual awards ceremony at World Bio Markets 2019 in Amsterdam on April 2, 2019.

World Bio Markets is one of the most established annual gathering points for the global bio-based economy — bringing together producers, investors, and policy leaders working across renewable chemicals, biofuels, bio-materials, and adjacent sectors. The Bio-Based Chemical Innovation of the Year Award specifically recognizes the technology breakthrough viewed as most likely to reshape commercial trajectories in the year ahead.

Microvi's MNE™ platform extends well beyond water and wastewater into the production of bio-based chemicals — including the multi-year butanol production work that has been advanced through DOE, USDA, and other federal grant programs. The 2019 recognition validated the bio-based chemicals strand of the platform alongside the more visible water and wastewater work.

Microvi has announced operational results from its sidestream treatment platform demonstrating up to 99% consistent removal of high-strength ammonia — a performance level that pushes the platform's nitrogen treatment capability past the most demanding operational thresholds in the global wastewater sector.

Sidestream treatment is one of the highest-leverage interventions in modern wastewater facility design. The high-strength filtrate returning from sludge dewatering carries a disproportionate share of the facility's total nitrogen mass, and treating it once — at the side, rather than mixing it back into the main plant influent — can dramatically reduce the facility's overall nitrogen burden.

Achieving 99% removal at the ammonia concentrations characteristic of sidestream filtrate is a structural validation of MNE™'s underlying biological capacity. The encapsulated, high-density biology can sustain treatment rates and removal efficiencies that conventional suspended-growth biological systems struggle to maintain in the same environment.

The result has anchored multiple subsequent sidestream deployments, including the Oro Loma full-scale installation that came online in 2021.

Scottish Water has launched a demonstration of Microvi's MNE™ wastewater treatment technology at its Wastewater Development Centre at Bo'ness — the centralized research and development facility through which Scottish Water evaluates emerging treatment technologies for potential deployment across its operating fleet.

Scottish Water is the public water and wastewater utility serving Scotland — covering more than 5 million people across the country. The Wastewater Development Centre is one of the most rigorous operational testing environments in the UK water sector, and inclusion in its evaluation program is a meaningful signal of technology readiness.

Against the backdrop of changing climatic conditions and capacity-limited treatment assets, Scottish Water has been actively seeking new technologies that can meet tightening Total Biochemical Oxygen Demand (TBOD) and ammonia standards while maintaining manageable total expenditures. The MNE™ demonstration is one strand of that broader evaluation.

The launch of the Bo'ness demonstration began a multi-year operational evaluation that subsequently produced the breakthrough ammonia and BOD removal results announced in 2019 and culminated in the 2020 Institute of Water Scottish Region Innovation Award.

Microvi has formed a partnership with Elemental Excelerator — one of the most influential climate-tech and clean-tech growth accelerators in the United States — receiving funding as part of Elemental's Equity and Access Track to implement nitrate removal projects in disadvantaged communities across California.

California's groundwater nitrate contamination problem is geographically concentrated in regions where the population is disproportionately low- and moderate-income. The cost gap between conventional nitrate treatment and what these communities can sustain has historically translated into sustained regulatory non-compliance and corresponding health outcomes that fall hardest on the populations least equipped to absorb them.

The Elemental Excelerator partnership specifically targets that gap. Microvi's MNE™ biological nitrate treatment delivers compliance at a fraction of the operating cost of conventional alternatives — and Elemental's Equity and Access funding offsets the capital cost barrier that has prevented disadvantaged communities from accessing the best available treatment technology.

The partnership has informed multiple deployments across California's most affected regions, including the Modesto project that subsequently became one of the platform's reference installations for community-scale drinking water service.

Microvi has implemented its MNE™ technology at a Thames Water wastewater treatment plant in the United Kingdom to demonstrate ammonia removal performance under cold temperature operating conditions — the most demanding operational envelope in the UK's seasonal cycle.

The demonstration plant, installed in collaboration with US engineering firm WesTech, is fully automated and configured as a tertiary nitrification system for ammonia removal. The configuration positions MNE™ as an intensification technology — embedded within the existing treatment train to increase capacity and effectiveness without requiring fundamental site reconstruction.

Intensification is a critical capability for Thames Water specifically and for the UK water sector broadly. London and the Thames Valley are projected to experience continued population growth across the coming decades, and the underlying wastewater infrastructure must accommodate that growth without proportional expansion of physical plant capacity.

MNE™'s structural advantage at low temperatures — sustained biological activity across 5°C to 22°C operating ranges — is one of the most important attributes for the UK winter operating envelope, and the Thames demonstration was designed specifically to validate that capability under field conditions.

A $2 million grant from the US Department of Energy has been awarded to a collaborative project — including Microvi — to develop an economical bio-based fuel additive that can be blended with diesel fuel to significantly reduce soot and greenhouse gas emissions while enabling cleaner engine operation in cold-weather conditions.

The project leverages Microvi's MNE™ platform to enable the cost-effective biological production of butyl acetate, a renewable fuel additive with significant performance advantages over conventional fossil-derived alternatives. Auburn University serves as a key academic partner on the program.

Bio-based fuel additives represent one of the most direct near-term decarbonization pathways for the heavy-duty diesel transportation sector — a sector that is structurally difficult to electrify and that will continue to operate on liquid fuels for the foreseeable future. Reducing the emissions intensity of those liquid fuels, through bio-based blending agents, is one of the highest-leverage interventions available.

The DOE program is one strand of Microvi's broader bio-based chemicals portfolio — extending the MNE™ platform from water and wastewater applications into renewable fuel and chemical production.

Microvi has demonstrated unprecedented titers of n-butanol production using its MNE™ platform — a result that significantly outperforms the titer and yield achievable with conventional fermentation processes for the same target molecule.

The trials, funded by a US Department of Agriculture (USDA) grant, validated that MNE™'s encapsulated, high-density biological matrix can sustain the operational conditions required for high-titer butanol production — overcoming the structural limitations that have historically constrained conventional fermentation-based bio-butanol economics.

n-Butanol is a critical bio-based chemical with applications across renewable fuels (as a gasoline additive with significantly better blending properties than ethanol), industrial solvents, and specialty chemicals. The economics of bio-butanol production have historically been constrained by the toxicity of butanol to the producing organisms themselves — fermentations slow or stop above a certain titer threshold, capping commercial output.

MNE™ structurally addresses that limitation by protecting the producing organisms within an encapsulated matrix, sustaining productivity at titers that conventional suspended-cell fermentations cannot maintain. The breakthrough result anchors Microvi's positioning in the broader bio-based chemicals market.

Microvi and Southern Water — one of the major UK water companies serving the south of England — have launched a demonstration of MNE™-based phosphorus removal and recovery, advancing the company's circular-economy approach to nutrient management in wastewater.

Conventional phosphorus removal relies primarily on chemical precipitation, typically with iron or aluminum coagulants. The approach meets discharge compliance, but at significant cost: it consumes substantial reagent volumes, generates chemical sludge that requires landfilling, and locks the recovered phosphorus into forms that have no value as agricultural fertilizer.

MNE™ takes a fundamentally different approach. Encapsulated biological organisms capture and concentrate phosphorus directly, producing a recoverable form that can be returned to agricultural soils — closing the nutrient loop rather than burying it. The Southern Water demonstration was designed to validate that capability in operational utility service.

The 2018 Southern Water program is one of the early threads of Microvi's UK phosphorus recovery portfolio — a portfolio that has since matured into the Cranfield BMPR partnership, the Ofwat Water Discovery Challenge win, and the operational demonstration now underway at Severn Trent's Minworth facility.

A large-scale demonstration of Microvi's MNE™ wastewater treatment technology has shown full nitrogen removal in less than two hours of hydraulic retention time — a performance level that fundamentally outperforms conventional biological nitrogen removal approaches in both treatment rate and treated effluent quality.

Installed in April 2018, the demonstration system has consistently achieved effluent total nitrogen (TN) levels below 3 mg/L — and at times as low as 1 mg/L — from influent ammonia concentrations as high as 45 mg/L. The combined nitrification-denitrification process operates at a hydraulic retention time of under two hours, with little to no biosolids generated.

The performance combination — high removal efficiency, low effluent concentrations, short retention time, and minimal biosolids — is structurally outside the operational envelope that conventional activated-sludge nitrogen removal can sustain. The demonstration validated MNE™'s underlying biological intensification capability at a scale and consistency that anchored multiple subsequent commercial deployments.

The results from this demonstration informed the technical case for the Bay Area Oro Loma sidestream selection later in 2019 and the broader portfolio of commercial nitrogen treatment installations that followed.

Microvi has demonstrated unprecedented removal rates of 1,2,3-Trichloropropane (TCP) and co-contaminants in drinking water using its cometabolism-based treatment technology — under a Phase II grant from the National Institutes of Health (NIH).

TCP is a persistent, mobile groundwater contaminant with significant public health implications. Conventional treatment technologies for TCP — including granular activated carbon — work, but at capital and operating costs that have limited deployment, particularly for smaller water systems serving rural communities.

Microvi's cometabolism approach uses MNE™-encapsulated organisms that biologically degrade TCP and structurally related co-contaminants — converting the parent compound to non-hazardous end products rather than simply transferring it from one medium to another. The result is unprecedented removal rates and a fundamentally lower operating cost profile.

The NIH Phase II program advanced the cometabolism platform toward commercial deployment for the communities most affected by TCP contamination, particularly in California's Central Valley where the contaminant is geographically concentrated.

The U.S. Environmental Protection Agency (EPA) has announced a combined $600,000 in funding for Microvi Biotech to advance environmental technology development programs at the company's Hayward, California facility.

EPA's small business technology development funding is one of the most consequential sources of non-dilutive capital available to early-stage environmental technology companies in the United States. The agency selectively funds research and development programs aligned with EPA's broader environmental protection mission — particularly in areas where the conventional regulatory toolkit faces technological or economic constraints.

For Microvi, the 2018 award funded continued advancement of the MNE™ platform across both water treatment and broader environmental applications. The cumulative impact of multi-year EPA partnership has been one of the foundational drivers of Microvi's technology trajectory — and was ultimately recognized through the EPA Administrator's Award for Outstanding Accomplishments by a Small Business Contractor in 2023.

The Metropolitan Water Reclamation District of Greater Chicago (MWRD) and Current — Chicago's water innovation organization — have launched their first joint technology pilot, selecting Microvi's MNE™ technology as the first deployment under the partnership.

The pilot evaluates MNE™ for the simultaneous removal of organics, ammonia, and phosphorus from wastewater — a multi-parameter performance challenge that conventional treatment technologies typically address through serial treatment steps, each with its own footprint, energy demand, and operational overhead.

MWRD serves the Chicago metropolitan area — one of the largest wastewater service territories in the United States. The agency's selection of MNE™ as the inaugural Current pilot signaled the broader Midwest water sector's interest in next-generation biological treatment approaches.

Current's role as Chicago's water innovation organization is to identify, evaluate, and accelerate the deployment of emerging water technologies across the regional utility landscape. The MNE™ selection placed Microvi at the front of that pipeline.

Microvi has received the Kirkpatrick Chemical Engineering Achievement Honor Award — recognition from one of the chemical engineering profession's most prestigious technical award programs — for its MNE™ process for biological nitrate removal from drinking water.

The Kirkpatrick Chemical Engineering Achievement Awards have been presented every two years since 1933 by Chemical Engineering magazine, recognizing the most noteworthy chemical engineering technology to enter commercial-scale operation during the preceding two years. The award is determined by a peer jury of leading chemical engineering academics and is widely regarded as one of the profession's highest honors.

The 2017 recognition placed MNE™ in the same lineage as the foundational chemical engineering innovations of the last century — and validated the platform not just as a water treatment technology, but as a chemical engineering achievement of broader significance.

For Microvi, the Kirkpatrick award marked an early but consequential signal that the underlying MNE™ science was being recognized at the highest levels of the engineering profession.

Microvi has been named to the Biofuels Digest Global Hot 40 list of the world's hottest emerging biotechnology companies — recognition that places Microvi alongside the most consequential emerging players in the global bioeconomy.

The Hot 40 rankings recognize biotechnology innovation and commercial achievement across the full breadth of the bioeconomy: renewable fuels, bio-based chemicals, nutrition, human health, synthetic biology, and materials. The list is curated annually by Biofuels Digest, the most-read daily publication in the bioeconomy.

The Hot 40 designation is specifically reserved for emerging companies — those founded in the past ten years and viewed as positioned to substantially shape the future direction of the industry. Inclusion validates not just current technology performance but the strategic trajectory of the organization across multiple sectors and product categories.

For Microvi, the recognition affirmed the breadth of the MNE™ platform's addressable market — extending well beyond water and wastewater into the broader bioeconomy applications that the company has continued to advance.

Microvi's MNE™ wastewater treatment technology has been accepted into the prestigious Leaders Innovation Forum for Technology (LIFT) program, with featured participation in the 2017 Intensification of Resource Recovery (IR²) Forum.

The LIFT program, operated by the Water Research Foundation in partnership with the Water Environment Federation (WEF), is one of the most influential channels in the US water sector for accelerating the evaluation, validation, and deployment of emerging treatment technologies. Acceptance into LIFT signals technology maturity and provides structured access to a national network of utility evaluation partners.

The 2017 IR² Forum, focused specifically on the intensification of resource recovery from wastewater, was a key venue for Microvi to present the MNE™ platform's capabilities to a national audience of utility leaders, engineering firms, and regulatory representatives.

The LIFT and IR² engagement helped accelerate the subsequent multi-year operational evaluations that have now produced the Oro Loma, Linda County, and broader Bay Area deployments at full commercial scale.

Microvi has been awarded grant funding to advance a new cost-effective bio-butanol production technology — featuring an intensified process that delivers significant operating cost reductions compared with conventional fermentation-based approaches.

The conventional economics of bio-butanol have been structurally limited by two factors: the relatively low titers achievable in conventional fermentation (which caps volumetric productivity), and the high energy and capital cost of the distillation step required to recover butanol from the aqueous fermentation broth.

Microvi's MNE™-based approach addresses both constraints simultaneously. The encapsulated, high-density biological matrix sustains higher butanol titers than conventional fermentation can support, and the intensified process design reduces — and in important cases nearly eliminates — the costly distillation step that has historically dominated the operating cost structure.

The collaboration includes Lawrence Berkeley National Laboratory's Advanced Biofuels and Bioproducts Process Development Unit (ABPDU), providing access to one of the most capable bio-process development environments in the United States.

Microvi has been recognized as the 2017 California Small Business of the Year — a designation that follows a sustained series of regional and industry recognitions earned across the same year.

The 2017 awards portfolio includes the Business Innovation Award, the Environmental Achievement Award, and a first-place finish in the East Bay Innovation Award in the clean tech category. Together, the recognitions reflect both the technical substance of the MNE™ platform and the broader business performance and community contribution that have characterized Microvi's trajectory through this period.

The California Small Business of the Year designation is awarded by state legislative offices to small businesses whose growth, innovation, and impact have substantially contributed to the state's economy. For Microvi, the recognition placed the company at the front of California's small-business clean-technology community — a positioning that has continued to inform the company's strategic engagement with state-level policy and regulatory institutions ever since.

Microvi has received both the 2017 Business Innovation Award and the 2017 Environmental Award — recognitions that together reflect the company's dual emphasis on technical innovation and operational sustainability.

The Environmental Award is presented to businesses, schools, and non-profit organizations whose work has substantially advanced sustainability — across waste reduction, energy efficiency, water conservation, and environmental education. For Microvi, the recognition reflects both the company's own operational sustainability practices and the structural environmental benefits delivered through its deployed MNE™ technology.

The Business Innovation Award recognizes organizations whose technology breakthroughs have substantially contributed to advancing their respective industries. For Microvi, the award was an early signal of the broader external recognition that has continued to follow MNE™ through subsequent years — culminating in the international recognitions including the World Economic Forum Technology Pioneer designation in 2019.

Microvi presented its 1,4-dioxane treatment technology at the American Chemical Society (ACS) National Meeting — one of the largest and most influential chemistry conferences in the world.

The presentation, titled "Bioprocess development for 1,4-dioxane treatment: Bench through field investigation," was delivered by Microvi's Director of Innovation Research Ameen Razavi. The talk traced the company's bioprocess development work for 1,4-dioxane from initial bench-scale validation through field-scale investigation — a structured technology development arc that has subsequently informed multiple Microvi applications.

1,4-dioxane is a known animal carcinogen with significant groundwater contamination implications. Conventional treatment technologies for 1,4-dioxane are technically demanding and operationally expensive — advanced oxidation processes are typically required, with high energy demand and complex chemical handling.

Microvi's biological approach to 1,4-dioxane addresses both the treatment efficacy and the cost-of-operation challenges that have historically constrained deployment. The ACS presentation brought that work into the broader chemistry community at a level of technical depth that the conference format supports.

Microvi has been named a winner of the East Bay Innovation Award — recognition from the East Bay Economic Development Alliance (EDA) celebrating cutting-edge innovators across one of the most consequential regional innovation economies in the United States.

The East Bay region — anchored by Berkeley, Oakland, Hayward, and the surrounding communities — has long been one of the most concentrated centers of clean-technology, biotechnology, and environmental engineering innovation in the country. The presence of Lawrence Berkeley National Laboratory, the University of California Berkeley, and a dense ecosystem of clean-tech companies creates a distinctive innovation environment that has produced an outsized share of the technology shaping global environmental practice.

The East Bay EDA was founded in 1990 as a public-private partnership to serve the East Bay area. Recognition through the EDA's Innovation Award signals broader regional acknowledgment of the company's contribution to the East Bay innovation economy.

For Microvi — headquartered in Hayward, in the heart of the East Bay — the recognition was an early validation that has continued to be reinforced through subsequent recognition cycles.

Microvi's nutrient removal technology has been featured in Global Water Intelligence (GWI) — the leading commercial intelligence publication for the global water sector. The article, titled "Is New Nitrogen Removal Tech Just Hot Air?", examined the rapidly expanding landscape of next-generation biological nitrogen removal technologies and the question of which approaches were likely to translate from laboratory promise into commercial impact.

GWI's editorial focus on emerging technology assessment carries substantial weight across the global water industry. Major utilities, technology procurement teams, investors, and policy bodies use GWI's coverage as a reference point for their own evaluations of the available technology landscape — meaning meaningful coverage in GWI translates directly into the strategic awareness that underpins commercial pipeline development.

The Microvi feature in GWI was one of the early indicators of the international water industry's growing attention to the MNE™ platform — and the subsequent multi-year arc of recognition (culminating in the Global Water Awards Breakthrough Technology Company of the Year in 2019) built on the visibility that GWI's coverage helped establish.

Microvi and the Sunny Slope Water Company in Pasadena, California have unveiled what was described at the time as the world's most advanced nitrate removal technology — a commercial-scale deployment of Microvi's MNE™ biocatalyst platform serving tens of thousands of households in Southern California.

The Sunny Slope deployment represented the operational maturation of a technology that had first been implemented for remote communities in Western Australia. The arc — from demonstration in remote Western Australia to commercial-scale deployment for a Southern California water utility — captures the global development trajectory of biological nitrate treatment, with Microvi positioned at the center.

The Sunny Slope partnership directly addresses Southern California's structural water crisis: limited local supply, persistent groundwater contamination, and growing demand from a large population in a water-constrained region. Biological nitrate treatment allows local groundwater that would otherwise be unusable to be safely brought back into the regional supply mix — at a cost the utility and its ratepayers can sustain.

Years later, the Sunny Slope deployment was selected as a foundational case study in the AWWA Manual M80 on Biological Drinking Water Treatment, establishing the system as one of the defining commercial references for the technology globally.

Microvi has welcomed Ajay Nair — a senior water industry executive with more than 20 years of international water industry experience — to the leadership team, strengthening the company's positioning in the UK and broader international water markets.

Mr. Nair brings 15 years of experience at MWH, one of the preeminent global water engineering firms. In his most recent role at MWH he served as Water and Wastewater Treatment Product Line and Technical Director — a position with global oversight responsibility across the firm's water and wastewater treatment technology portfolio.

The recruitment reflects Microvi's sustained investment in the seniority and depth of the team responsible for engaging directly with regulated water utilities globally. The UK water sector specifically, with its highly structured AMP regulatory cycle and concentrated set of major regulated water companies, requires a level of relationship continuity and technical credibility that the company's subsequent UK expansion has built upon.

Strategic senior hires of this kind have anchored Microvi's growth into one of the most internationally recognizable next-generation water technology companies in the world.

Microvi has been awarded a contract to advance its highly efficient biological phosphorus removal technology — using specialized natural organisms to reduce phosphorus concentrations in wastewater to below 0.1 mg/L, a treatment threshold that fundamentally outperforms what conventional chemical precipitation can sustainably achieve.

Just as importantly, the technology enables recovery of the captured phosphorus into a form that can be converted into agricultural fertilizer — closing the planetary phosphorus loop rather than locking the recovered nutrient into the inert chemical sludge that conventional chemical precipitation produces.

Phosphorus is a finite, essential agricultural nutrient. Global phosphorus reserves are geographically concentrated and finite, and the global agricultural economy is structurally dependent on a continuing supply. Recovering phosphorus from wastewater — at the discharge end of the food system — is one of the most direct ways to begin closing the loop on a resource flow that is increasingly recognized as strategically critical.

The 2016 contract was one of the foundational programs that has since matured into Microvi's broader phosphorus portfolio, including the BMPR partnership with Cranfield University, the Ofwat Discovery Challenge win, and the Severn Trent Minworth demonstration.

The U.S. Department of Energy (DOE) has awarded Microvi a grant for the development of an innovative biogas conversion technology — using the MNE™ platform to convert biogas generated at landfills, wastewater treatment plants, and similar facilities into high-value energy chemicals including biobutanol.

Biogas — primarily methane and CO₂ — is generated continuously at thousands of landfills and wastewater treatment plants across the United States. Most of that biogas is either flared (converting it directly to CO₂ with no captured value), used in modest amounts for on-site heat or power, or vented as fugitive emissions that contribute disproportionately to greenhouse gas inventories.

Converting that biogas stream into a higher-value chemical product — rather than burning it for low-grade energy — fundamentally changes both the economic and the environmental balance. The product chemicals (such as biobutanol) replace fossil-derived equivalents, the underlying biogas is captured rather than emitted, and the host facility (landfill or wastewater plant) gains a revenue-generating resource recovery pathway.

The DOE-funded program is one of the foundational strands of Microvi's portfolio at the intersection of waste streams, renewable energy, and bio-based chemicals.

Microvi presented two technical white papers at WEFTEC 2016 — the Water Environment Federation's annual technical exhibition and conference, the largest annual gathering of the global wastewater treatment community.

The presentations focused on recent projects that had operationally proven the effectiveness of Microvi's MNE™ nutrient removal technology — combining technical performance data with the operational context that wastewater treatment professionals need to evaluate technology for deployment in their own facilities.

WEFTEC is one of the most consequential venues in the global water sector. The annual conference brings together utility leaders, engineering consultants, regulators, technology providers, and academic researchers in a concentrated week-long technical exchange. Technology providers who present rigorous, operationally-grounded results at WEFTEC subsequently find that their pipeline of utility engagement accelerates meaningfully in the following 6–18 months.

Microvi's WEFTEC presentations across multiple years have been one of the consistent foundations of the company's commercial engagement with the US municipal wastewater sector.

Microvi's Denitrovi™ nitrate removal technology has been validated as highly effective through an independent demonstration program with the City of Avondale, Arizona — successfully treating groundwater with influent nitrate concentrations ranging from 6.6 to 14.7 mg/L and reducing those levels to acceptable compliance values across three phases of structured testing.

The Avondale demonstration was one of the earliest independent operational validations of Denitrovi™ in the American Southwest — a region where groundwater nitrate contamination has been one of the most persistent and consequential drinking water challenges. The Water Research Foundation was a key partner in structuring the independent evaluation framework.

Independent evaluations like the Avondale program are particularly valuable to the broader water utility community because the technology performance is documented and validated outside the technology provider's own operational context. The Avondale results subsequently supported the broader procurement and engineering case that ultimately drove the Goodyear, Arizona commercial commissioning announced in 2022 — and continues to inform the platform's expansion across the Arizona water sector.

Microvi's CEO, Dr. Fatemeh Shirazi, presented at the Bioeconomy Conference — speaking about the paradigm shifts enabled by Microvi's MNE™ platform and its implications for the cost-effective production of biofuels and bio-based chemicals.

The Bioeconomy Conference brings together leaders from across the renewable chemicals, biofuels, and bio-based materials sectors — including producers, investors, federal funders, and policy leaders shaping the broader trajectory of the global bioeconomy. Dr. Shirazi's keynote outlined the conceptual and operational framework that underpins the MNE™ platform's distinctive capability to make biological production processes substantially more reliable and economical than conventional fermentation-based approaches.

The 2015 conference appearance is one of the earliest publicly archived presentations of the MNE™ platform's positioning to a broad bioeconomy audience — and the strategic framing established in that talk has continued to shape the company's external communication ever since.

Dr. Shirazi's continued public leadership across the broader bioeconomy has been one of the foundational drivers of Microvi's evolution into one of the most internationally recognizable next-generation biological technology companies in the world.